A self-assembling peptide hydrogel was engineered to release wound-healing peptides like GHK only when triggered by wound-related enzymes, improving skin healing in mice.
Enzyme-triggered healingHydrogel releases wound-healing peptides only when it detects neutrophil elastase — an enzyme present at injury sites — creating on-demand drug delivery
What the researchers found
Researchers created three new peptide hydrogel materials by combining the self-assembling RADA16-I scaffold with biologically active wound-healing peptide motifs (GHK, KGHK, and RDKVYR) connected through an enzyme-cleavable linker (AAPV). The design is smart: when wound-related enzymes (neutrophil elastase) encounter the hydrogel, they cut the linker and release the active healing peptides at the wound site.
The hybrid materials maintained the same gelling properties as the original RADA16-I scaffold, showed no toxicity to skin cells, and promoted better cell growth than the unmodified gel. In mice with dorsal skin wounds, topical application of RADA-GHK and RADA-KGHK hydrogels improved wound healing as confirmed by histological analysis.
Why it matters
Wound healing peptides like GHK are effective but break down quickly, requiring repeated application. This hydrogel system solves that problem by acting as both a protective scaffold for new skin cells and a controlled-release reservoir that only delivers healing peptides when wound-related enzymes are present. This enzyme-triggered release is an elegant design — the gel responds to the wound environment itself.
The numbers in context
Three hybrid peptide materials (RADA-GHK, RADA-KGHK, RADA-RDKVYR); AAPV elastase-cleavable linker; no cytotoxicity in fibroblasts/keratinocytes; improved cell proliferation vs RADA16-I alone; improved wound healing in mouse dorsal skin model
How the study worked
The researchers synthesized three hybrid peptides and characterized them using circular dichroism, thioflavin T assay, transmission electron microscopy, atomic force microscopy, scanning electron cryomicroscopy, and rheological testing. They tested stability in water and plasma, and enzyme susceptibility. Cytotoxicity was assessed on fibroblasts and keratinocytes using XTT and LDH assays. Wound healing was evaluated in a mouse dorsal skin injury model with histological analysis.
Who was studied
Mouse dorsal skin wound model; in vitro human fibroblast and keratinocyte cultures
What this study cannot tell us
Wound healing was only demonstrated in a mouse model, and mouse skin heals differently from human skin. The abstract doesn't report specific wound closure rates, healing times, or quantitative comparisons. Only two of the three hybrid peptides (RADA-GHK and RADA-KGHK) were tested in the wound model — RADA-RDKVYR results aren't mentioned for in vivo. Long-term biocompatibility and manufacturing scalability are unknown.
How to read the evidence
This is preliminary preclinical research combining in vitro characterization with a mouse wound model. The results are promising but early-stage, with no human data, no quantitative healing metrics reported in the abstract, and only two of three formulations tested in vivo.
When this study was published
Published in 2023, this is recent research at the frontier of peptide-based biomaterials for wound healing.
The bigger picture
Self-assembling peptide hydrogels represent a growing area of regenerative medicine. The innovation here is the enzyme-responsive release mechanism — the material doesn't just passively release peptides over time, it specifically responds to wound-related enzymes. This approach could be applied beyond wound healing to deliver anti-inflammatory or antimicrobial peptides in other tissue engineering applications where enzyme-triggered drug release would be beneficial.
Questions still open
- How does the wound healing speed and quality compare to standard wound dressings or other growth factor treatments?
- Could this enzyme-responsive release platform be loaded with different active peptides for specific wound types (burns, diabetic ulcers, surgical wounds)?
- What is the shelf life and manufacturing scalability of these hybrid peptide hydrogels?
Common questions
What is GHK and why is it used in wound healing?
How does the hydrogel know when to release the healing peptides?
Read the original research
Release systems based on self-assembling RADA16-I hydrogels with a signal sequence which improves wound healing processes.
Scientific reports, 13(1), 6273
Citation
Dzierżyńska, Maria; Sawicka, Justyna; Deptuła, Milena; Sosnowski, Paweł; Sass, Piotr; Peplińska, Barbara; Pietralik-Molińska, Zuzanna; Fularczyk, Martyna; Kasprzykowski, Franciszek; Zieliński, Jacek; Kozak, Maciej; Sachadyn, Paweł; Pikuła, Michał; Rodziewicz-Motowidło, Sylwia. (2023). Release systems based on self-assembling RADA16-I hydrogels with a signal sequence which improves wound healing processes.. Scientific reports, 13(1), 6273. https://doi.org/10.1038/s41598-023-33464-w